Skip to main content
Home

Main navigation

  • About HIPRA

      About HIPRA

    • Discover HIPRA
    • History
    • Sustainability & CSR
    • HIPRA Around the World
  • Animal Health

      Animal Health

    • Products
      • Vaccines
      • Diagnostic kits
      • Pharmaceuticals
    • Services
      • About Smart Vaccination
      • HIPRASTATS
      • HIPRA Diagnos
      • HIPRA University
      • Online Calculators
    • Knowledge
    • News
    • Solutions for
      • Swine
      • Poultry
      • Cattle
      • Sheep and goats
      • Rabbits
      • Fish
      • Dogs
  • Human Health

      Human Health

    • Products
      • Covid-19 Vaccine
      • GoodGut: digestive health
    • R&D projects
    • News
    • Press
  • Careers
  • Contact us
Career
Search
Search

Press

who we are
Press
01/17/2023 - 14:29

HIPRA’s COVID-19 vaccine trial in people with immunocompromising conditions was launched in Turkey

Human
Explore
11/07/2022 - 17:20

HIPRA starts a clinical trial to study its vaccine against COVID-19 as a 4th dose

Human
Explore
07/19/2022 - 10:14

HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the BA.2, BA.4 and BA.5 subvariants of Omicron

Human
Explore
05/18/2022 - 10:13

HIPRA initiates the first Phase III clinical trial of Covid-19 vaccine in immunocompromised people

Human
Explore
03/29/2022 - 14:02

EMA starts rolling review of Covid-19 HIPRA’s vaccine

Human
Explore
03/16/2022 - 08:45

GoodGut and Vall d'Hebron Barcelona Hospital are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

Human
Explore
  • Load More
Home

Footer second

  • About HIPRA
  • Animal Health
  • Human Health

Footer third

  • Careers
  • Contact us

Footer fourth

  • LinkedIn
  • YouTube

Footer

  • Terms of use
  • Privacy policy
  • Cookies policy